Sinopharm Group Co. Ltd (X2S) — Strategic Asset Allocation Index
Sinopharm Group Co. Ltd (X2S) has a Strategic Asset Allocation Index of 17.4% as of June 2023. Strategic assets (PP&E of €19.66 Billion plus long-term investments of €-) total €19.66 Billion, measured against net assets of €113.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Sinopharm Group Co. Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Sinopharm Group Co. Ltd Strategic Asset Allocation Index (2013–2022)
This chart shows how Sinopharm Group Co. Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 17.4%, representing strategic assets of €19.66 Billion against net assets of €113.11 Billion EUR. See X2S financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Sinopharm Group Co. Ltd (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sinopharm Group Co. Ltd from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see X2S stock market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.8% | €19.65 Billion | €19.65 Billion | €- | €110.07 Billion | ▼ -1.6 pp |
| 2021 | 19.5% | €19.41 Billion | €19.41 Billion | €- | €99.65 Billion | ▼ -1.5 pp |
| 2020 | 21.0% | €18.90 Billion | €18.90 Billion | €- | €89.95 Billion | ▼ -2.5 pp |
| 2019 | 23.5% | €18.06 Billion | €18.06 Billion | €- | €76.94 Billion | ▼ -3.0 pp |
| 2018 | 26.5% | €18.09 Billion | €11.03 Billion | €7.07 Billion | €68.28 Billion | ▼ -3.3 pp |
| 2017 | 29.8% | €15.29 Billion | €9.01 Billion | €6.28 Billion | €51.27 Billion | ▲ +6.1 pp |
| 2016 | 23.7% | €10.55 Billion | €6.75 Billion | €3.79 Billion | €44.53 Billion | ▲ +1.4 pp |
| 2015 | 22.3% | €9.10 Billion | €7.64 Billion | €1.46 Billion | €40.88 Billion | ▼ -0.8 pp |
| 2014 | 23.1% | €8.38 Billion | €7.10 Billion | €1.28 Billion | €36.29 Billion | ▼ -2.5 pp |
| 2013 | 25.6% | €7.32 Billion | €6.31 Billion | €1.01 Billion | €28.61 Billion | — |